Use of electroneuronography in monitoring facial nerve paralysis.

W. M. Lydiatt, A. Sobba-Higley, P. Morrow, Gary Floyd Moore

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

FNP is a disease entity seen in a variety of clinical settings. We recommend early ENoG evaluation of every total facial nerve paralysis to assess the percentage of degeneration. ENoG is an objective, permanent record with prognostic significance especially in 16% of those patients who are predicted to have a poor outcome without further intervention. In consultation with the patient a treatment plan can thus be proposed to optimize the opportunity for recovery.

Original languageEnglish (US)
Pages (from-to)231-234; discussion 235
JournalThe Nebraska medical journal
Volume77
Issue number8
StatePublished - Aug 1992

Fingerprint

Facial Paralysis
Facial Nerve
Referral and Consultation
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lydiatt, W. M., Sobba-Higley, A., Morrow, P., & Moore, G. F. (1992). Use of electroneuronography in monitoring facial nerve paralysis. The Nebraska medical journal, 77(8), 231-234; discussion 235.

Use of electroneuronography in monitoring facial nerve paralysis. / Lydiatt, W. M.; Sobba-Higley, A.; Morrow, P.; Moore, Gary Floyd.

In: The Nebraska medical journal, Vol. 77, No. 8, 08.1992, p. 231-234; discussion 235.

Research output: Contribution to journalArticle

Lydiatt, WM, Sobba-Higley, A, Morrow, P & Moore, GF 1992, 'Use of electroneuronography in monitoring facial nerve paralysis.', The Nebraska medical journal, vol. 77, no. 8, pp. 231-234; discussion 235.
Lydiatt WM, Sobba-Higley A, Morrow P, Moore GF. Use of electroneuronography in monitoring facial nerve paralysis. The Nebraska medical journal. 1992 Aug;77(8):231-234; discussion 235.
Lydiatt, W. M. ; Sobba-Higley, A. ; Morrow, P. ; Moore, Gary Floyd. / Use of electroneuronography in monitoring facial nerve paralysis. In: The Nebraska medical journal. 1992 ; Vol. 77, No. 8. pp. 231-234; discussion 235.
@article{740fee8a915c412294e36ab9e29c72ec,
title = "Use of electroneuronography in monitoring facial nerve paralysis.",
abstract = "FNP is a disease entity seen in a variety of clinical settings. We recommend early ENoG evaluation of every total facial nerve paralysis to assess the percentage of degeneration. ENoG is an objective, permanent record with prognostic significance especially in 16{\%} of those patients who are predicted to have a poor outcome without further intervention. In consultation with the patient a treatment plan can thus be proposed to optimize the opportunity for recovery.",
author = "Lydiatt, {W. M.} and A. Sobba-Higley and P. Morrow and Moore, {Gary Floyd}",
year = "1992",
month = "8",
language = "English (US)",
volume = "77",
pages = "231--234; discussion 235",
journal = "The Nebraska medical journal",
issn = "0091-6730",
publisher = "Nebraska State Medical Association",
number = "8",

}

TY - JOUR

T1 - Use of electroneuronography in monitoring facial nerve paralysis.

AU - Lydiatt, W. M.

AU - Sobba-Higley, A.

AU - Morrow, P.

AU - Moore, Gary Floyd

PY - 1992/8

Y1 - 1992/8

N2 - FNP is a disease entity seen in a variety of clinical settings. We recommend early ENoG evaluation of every total facial nerve paralysis to assess the percentage of degeneration. ENoG is an objective, permanent record with prognostic significance especially in 16% of those patients who are predicted to have a poor outcome without further intervention. In consultation with the patient a treatment plan can thus be proposed to optimize the opportunity for recovery.

AB - FNP is a disease entity seen in a variety of clinical settings. We recommend early ENoG evaluation of every total facial nerve paralysis to assess the percentage of degeneration. ENoG is an objective, permanent record with prognostic significance especially in 16% of those patients who are predicted to have a poor outcome without further intervention. In consultation with the patient a treatment plan can thus be proposed to optimize the opportunity for recovery.

UR - http://www.scopus.com/inward/record.url?scp=0026905930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026905930&partnerID=8YFLogxK

M3 - Article

C2 - 1508285

AN - SCOPUS:0026905930

VL - 77

SP - 231-234; discussion 235

JO - The Nebraska medical journal

JF - The Nebraska medical journal

SN - 0091-6730

IS - 8

ER -